The updated ICH GCP E6(R3) guideline has arrived, with major structural and content changes affecting clinical trials. Download our whitepaper for analysis, risk impact assessments and compliance strategies from ICON’s Regulatory Affairs experts. https://ow.ly/TLkO50WUY9X | ICON Plc

❓ How can pediatric clinical trials ensure safe and timely access to treatments for children? Join ICON for a webinar with Heather Peterson and Jo Dewhurst to explore regulatory strategies, Pediatric Investigation Plans (PIPs), and Pediatric Study Plans (PSPs). Learn how ICON’s Pediatric Risk Assessment Map (PRAM) can help assess, quantify, and mitigate risks across pediatric-inclusive programs. Register now: https://buff.ly/JmZVxFL #PediatricClinicalTrials #RegulatoryStrategy #PediatricDevelopm